NEW

Health Care Leaders Form Trustworthy & Responsible AI Network (TRAIN)

Monday, at the HIMSS 2024 Global Health Conference, a new consortium of healthcare leaders announced the creation of the Trustworthy & Responsible AI Network (TRAIN), which aims to operationalize responsible AI principles to improve the quality, safety and...

EPA Rule to Slash EtO Emissions, Reduce Cancer Risk

The U.S. Environmental Protection Agency has announced a rule that will reduce lifetime cancer risks for people living near commercial sterilization facilities across the country. The final amendments to the air toxics standards for ethylene oxide commercial...

AI Revolutionizes General Surgery, says GlobalData

Artificial intelligence (AI) integration in general surgery has surged, promising revolutionary advancements in precision and patient outcomes. AI tools have transformed preoperative planning, intraoperative assistance, and postoperative care, enhancing diagnostic...

Study Shows Potential for Using AI Tools to Detect Healthcare-Associated Infections

A new proof-of-concept study published today in the American Journal of Infection Control (AJIC) reports that artificial intelligence (AI) technologies can accurately identify cases of healthcare-associated infections (HAI) even in complex clinical scenarios. The...

Medtronic Recalls Valiant Navion Thoracic Stent Graft System

FDA

The FDA has identified this as a Class I recall, the most serious type of recall. Use of these devices may cause serious injuries or death.

Recalled Product

  • Medtronic Valiant Navion Thoracic Stent Graft System
  • Model Number, Product Codes, Catalog or Lot numbers: Please See Links Below.
  • Distribution Dates: November 12, 2018 to February 10, 2021
  • Devices Recalled in the U.S.: 14,237
  • Date Initiated by Firm: February 4, 2021

Device Use

The Valiant Navion Thoracic Stent Graft System is designed to repair lesions of the descending thoracic aorta, located in the body’s largest artery (aorta) which passes through the lower part of the chest. A surgeon uses a long tube-like device (catheter) to place the stent graft inside the aorta. Once placed, the stent expands to fit within the aorta to provide a new path for blood to flow from the heart to the lower part of the body.

Reason for Recall

Medtronic is recalling the Valiant Navion Thoracic Stent Graft System due to stent fractures and endoleak concerns. Following device implantation, patients may experience stent ring enlargement beyond design specification, stent fractures, holes in the graft fabric (Type III endoleaks), life-threatening bleeding, aortic rupture, or death.

There have been 11 reported issues related to this device including two injuries and one death. There have been four cases of Type III endoleak, four cases of stent facture, and seven cases of stent ring enlargement. Some patients experienced multiple findings.

Who May be Affected

  • Health care providers using the affected Medtronic device
  • Patients who were implanted with the affected Medtronic device

What to Do

On February 12, 2021, Medtronic sent an Urgent Medical Device Recall notification to all affected customers. Recommendations were offered to help physicians and patients evaluate the risks of the device.

Physician Recommendations:

  • Immediately cease use of the stent graft system and follow instructions for returning unused products to Medtronic.
  • Review all available images of patients treated with the stent graft system and contact Medtronic if any findings are observed.
  • Follow best clinical practices and evaluate patients with at least annual follow-up.
  • Notify Medtronic of any adverse events or product safety issues associated with the device.

Patients with an implant card after surgery for the Medtronic Valiant Navion Thoracic Stent Graft System should consult their physician with any questions.

Contact Information

Customers with questions about this recall should contact Medtronic Customer Service at 1-888-283-7868.

Full List of Affected Devices

Additional Resources:

How to report a problem

Health care professionals and consumers may report adverse reactions or quality problems they experienced using these devices to MedWatch: The FDA Safety Information and Adverse Event Reporting Program using an online form, regular mail, or FAX.

Previous

Next

Submit a Comment

Your email address will not be published. Required fields are marked *

X